These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8186867)

  • 1. Hepatic arterial infusion of verapamil and doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration: pharmacological evaluation of reduction in systemic drug exposure and assessment of hepatic toxicity.
    Fuhrman GM; Cromeens DM; Newman RA; Cleary KR; Carrasco CH; Wright KC; Guercio S; Guercio A; Curley SA
    Surg Oncol; 1994 Feb; 3(1):17-25. PubMed ID: 8186867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration.
    Curley SA; Byrd DR; Newman RA; Ellis HJ; Chase J; Carrasco CH; Cleary K; Bodden W; Hohn DC
    Surgery; 1993 Sep; 114(3):579-85. PubMed ID: 8367814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: a feasibility study of a novel system.
    Curley SA; Byrd DR; Newman RA; Carrasco CH; Cromeens D; Ellis HJ; Chase J; Dougherty T; Wright K; Bodden W
    Anticancer Drugs; 1991 Apr; 2(2):175-83. PubMed ID: 1958862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration.
    Curley SA; Stone DL; Fuhrman GM; Hohn DC; Siddik ZH; Newman RA
    Cancer Chemother Pharmacol; 1993; 33(3):251-7. PubMed ID: 8269607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study.
    Curley SA; Newman RA; Dougherty TB; Fuhrman GM; Stone DL; Mikolajek JA; Guercio S; Guercio A; Carrasco CH; Kuo MT
    Ann Surg Oncol; 1994 Sep; 1(5):389-99. PubMed ID: 7850540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors.
    Ravikumar TS; Pizzorno G; Bodden W; Marsh J; Strair R; Pollack J; Hendler R; Hanna J; D'Andrea E
    J Clin Oncol; 1994 Dec; 12(12):2723-36. PubMed ID: 7989950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of percutaneous hepatic venous isolation for administration of regional chemotherapy.
    August DA; Verma N; Vaerten MA; Shah R; Andrews JC; Brenner DE
    Surg Oncol; 1995 Aug; 4(4):205-16. PubMed ID: 8528483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe anesthetic management of patients undergoing a novel method of treating human hepatocellular cancer.
    Dougherty TB; Mikolajek JA; Curley SA
    J Clin Anesth; 1997 May; 9(3):220-7. PubMed ID: 9172030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of hepatic doxorubicin extraction with extracorporeal filtration avoids the dose-dependent, nonlinear increase in AUC observed with systemic administration.
    Sturgill MG; Brenner DE; August DA
    Cancer Chemother Pharmacol; 1998; 41(3):193-200. PubMed ID: 9443635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model.
    Yee C; McCoy D; Yu J; Losey A; Jordan C; Moore T; Stillson C; Oh HJ; Kilbride B; Roy S; Patel A; Wilson MW; Hetts SW;
    Radiol Imaging Cancer; 2019 Sep; 1(1):e190009. PubMed ID: 32300759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal carbon chemofiltration under hepatic venous isolation for high-dose intraarterial chemotherapy of the liver.
    Ku Y; Saitoh Y
    Surgery; 1994 Nov; 116(5):941. PubMed ID: 7818674
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic artery infusion of doxorubicin with hepatic venous drug extraction.
    August DA; Verma N; Andrews JC; Vaerten MA; Brenner DE
    J Surg Res; 1994 Jun; 56(6):611-9. PubMed ID: 8015319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance.
    Saltz L; Murphy B; Kemeny N; Bertino J; Tong W; Keefe D; Tzy-Jun Y; Tao Y; Kelsen D; O'Brien JP
    Cancer; 1994 Nov; 74(10):2757-64. PubMed ID: 7954234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
    Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
    Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of cytotoxicity of doxorubicin by verapamil in the hepatic artery infusion for liver tumors in rats.
    Miyazaki M; Shimoda T; Itoh H; Kaiho T; Iinuma K; Koyama T; Nakagawa K; Andoh K; Anbiru S; Ohtawa S
    Cancer; 1993 Jul; 72(2):349-54. PubMed ID: 8319168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of verapamil and degradable starch microspheres during hepatic artery infusion of doxorubicin.
    Thom AK; Zhang SZ; Deveney C; Daly JM
    Surgery; 1990 May; 107(5):552-9. PubMed ID: 2333595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic and clinical research on the therapeutic effect of intervention in primary liver cancer by targeted intra-arterial verapamil infusion.
    Pingsheng F; Tengyue Z; Qiang H; Qiang W; Xin S; Liting Q
    Cell Biochem Biophys; 2012 Jan; 62(1):59-67. PubMed ID: 21830124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New approach for unresectable primary liver cancer--intra-arterial combination chemotherapy during and after operation with local injection of ethanol].
    Shiga T; Noguchi T; Nishimaki K; Kudo M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2765-8. PubMed ID: 2551220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical trial of arterial infusion chemotherapy combined with calcium antagonist for liver metastases].
    Matsumoto J; Minami T; Sato T; Onodera T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1553-6. PubMed ID: 1530306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM; Yang JM; Hait WN
    Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.